Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference72 articles.
1. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study;Cortes;Lancet,2011
2. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial;Schöffski;Lancet,2016
3. Halaven (eribulin mesylate) injection [prescribing information]. Woodcliff Lake, NJ: Eisai Inc.; 2016.
4. Halaven 0.44 mg/ml solution for injection [summary of product characteristics]. Hertfordshire, UK: Eisai Europe Limited.
5. Broad spectrum preclinical antitumor activity of eribulin (Halaven®): optimal effectiveness under intermittent dosing conditions;Towle;Anticancer Res,2012
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献